Risultati di ricerca
Padmanee Sharma (born June 26, 1970) is an immunologist and oncologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. She holds the position of professor of genitourinary medical oncology and immunology in the Division of Cancer Medicine where she specializes in renal, prostate, and bladder cancers.
Dr. Sharma is a nationally and internationally renowned physician scientist who is a pioneer in the field of immune checkpoint therapy. In 2006, Dr. Sharma designed and conducted the first neoadjuvant (pre-surgical) clinical trial with immune checkpoint therapy.
Dr. Sharma is an elected Fellow of the AACR, Class of 2024.
3 apr 2024 · Padmanee Sharma, M.D., Ph.D., associate vice president of Immunobiology, professor of Genitourinary Medical Oncology and Immunology, and director of scientific programs for the James P. Allison Institute at The University of Texas MD Anderson Cancer Center, has been elected to the 2024 class of Fellows of the American Association for ...
Immune checkpoint therapy (ICT) can provide durable clinical responses and improve overall survival. However, only subsets of patients with specific tumor types respond to ICT.
- Padmanee Sharma, Bilal A. Siddiqui, Swetha Anandhan, Shalini S. Yadav, Sumit K. Subudhi, Jianjun Gao...
- 2021
9 nov 2022 · 1 Padmanee Sharma is a professor of Genitourinary Medical Oncology and Immunology, the scientific director of the Immunotherapy Platform, and the director of Scientific Programs of the James P. Allison Institute at The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Email: padsharma@mdanderson.org.
Dr. Padmanee Sharma is a professor in the departments of genitourinary medical oncology and immunology, and the scientific director for the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center.
